This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
The Investor Outlook series will focus on specific indicators that measure what investors are thinking and doing about the market. This article looks at...
In November of last year I believed that shares of Thermo Fisher Scientific (NYSE:TMO) were on the road to discovery, delivering on impressive results...